InsidersTradesSigma
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Innoviva, Inc.. Officer active across 2 companies, notably Entasis Therapeutics Holdings Inc.. Aggregated, 9 reports have been recorded. Total volume traded: €95.8m. The latest transaction was filed on 31 March 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations9 total
€24m5,385,208 shares@ €4.51578.23% mcap38.7% of flow
Common Stock
SEC:0001567619-22-007861:0·
Ideal exit: 26 Dec 2022 (T+270)
€16m3,614,792 shares@ €4.377882.2% of flow
Common Stock
SEC:0001567619-22-003750·
Ideal exit: 6 Nov 2022 (T+270)
€16m3,614,792 shares@ €4.37785.35% mcap25.2% of flow
Common Stock
SEC:0001567619-22-003750:0·
Ideal exit: 6 Nov 2022 (T+270)
€3m1,212,122 shares@ €2.824517.8% of flow
Common Stock
SEC:0001567619-21-019063·
Ideal exit: 26 Jul 2022 (T+270)
€3m1,212,122 shares@ €2.82451.16% mcap5.5% of flow
Common Stock
SEC:0001567619-21-019063:0·
Ideal exit: 26 Jul 2022 (T+270)
€10m6,268,975 shares@ €1.64331.2% of flow
Common Stock
SEC:0001567619-21-012030:0·
Ideal exit: 8 Mar 2022 (T+270)
€10m6,268,975 shares@ €1.64362.5% of flow
Common Stock
SEC:0001567619-21-012030·
Ideal exit: 8 Mar 2022 (T+270)
€6m3,731,025 shares@ €1.658237.5% of flow
Common Stock
SEC:0001567619-21-010772·
Ideal exit: 28 Jan 2022 (T+270)
€6m3,731,025 shares@ €1.658218.8% of flow
Common Stock
SEC:0001567619-21-010772:0·
Ideal exit: 28 Jan 2022 (T+270)
9 of 9 declarations
About Innoviva, Inc.
Innoviva, Inc. is a director and insider at Entasis Therapeutics Holdings Inc. and Armata Pharmaceuticals, Inc.
